(BVI) Bureau Veritas - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0006174348
Stock:
Total Rating 53
Risk 87
Buy Signal -0.31
| Risk 5d forecast | |
|---|---|
| Volatility | 19.1% |
| Relative Tail Risk | -5.17% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.13 |
| Alpha | -5.60 |
| Character TTM | |
|---|---|
| Beta | 0.496 |
| Beta Downside | 0.452 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.96% |
| CAGR/Max DD | 0.36 |
Description: BVI Bureau Veritas
Bureau Veritas SA provides laboratory testing, inspection, and certification services. It operates through six segments: Marine & Offshore; Agri-Food & Commodities; Industry; Buildings & Infrastructure; Certification; and Consumer Products services. The company engages in inspecting, analyzing, auditing, and certifying the products, assets, and management systems of its clients in relation to regulatory or self-imposed standards, as well as issues compliance reports. It also provides technical services for marine and offshore; inspection, audit, certification, and testing services for oil and petrochemicals, metals and minerals, and agri-food; technical control, code compliance, independent technical assistance, quality assurance/quality control, construction management, and project management assistance; laboratory and on-site testing services for manufacturing and process industries; inspection services for products, services, assets, and installations, as well as various services designed to reduce risk, control quality, verify quantity, and meet regulatory requirements; and certification services for management systems, products, and people. The company serves construction and civil engineering, real estate, transportation, oil and gas, marine and offshore, nuclear, defense, automotive, aerospace, IT, electronics, power and utilities, consumer products, and retail industries, as well as financial services and public sectors. It operates in approximately 140 countries through a network of offices and laboratories. Bureau Veritas SA was founded in 1828 and is headquartered in Neuilly-sur-Seine, France.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 1.16b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.23 > 0.02 and ΔFCF/TA 11.58 > 1.0 |
| NWC/Revenue: 3.48% < 20% (prev 12.85%; Δ -9.37% < -1%) |
| CFO/TA 0.28 > 3% & CFO 1.82b > Net Income 1.16b |
| Net Debt (1.72b) to EBITDA (2.48b): 0.69 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (451.5m) vs 12m ago -1.12% < -2% |
| Gross Margin: 48.41% > 18% (prev 0.33%; Δ 4809 % > 0.5%) |
| Asset Turnover: 182.4% > 50% (prev 120.3%; Δ 62.14% > 0%) |
| Interest Coverage Ratio: 9.22 > 6 (EBITDA TTM 2.48b / Interest Expense TTM 207.2m) |
Altman Z'' 3.54
| A: 0.07 (Total Current Assets 2.92b - Total Current Liabilities 2.48b) / Total Assets 6.56b |
| B: 0.21 (Retained Earnings 1.39b / Total Assets 6.56b) |
| C: 0.28 (EBIT TTM 1.91b / Avg Total Assets 6.85b) |
| D: 0.52 (Book Value of Equity 2.62b / Total Liabilities 5.08b) |
| Altman-Z'' Score: 3.54 = A |
Beneish M -3.26
| DSRI: 0.70 (Receivables 2.03b/1.98b, Revenue 12.49b/8.59b) |
| GMI: 0.67 (GM 48.41% / 32.59%) |
| AQI: 1.14 (AQ_t 0.43 / AQ_t-1 0.38) |
| SGI: 1.46 (Revenue 12.49b / 8.59b) |
| TATA: -0.10 (NI 1.16b - CFO 1.82b) / TA 6.56b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of BVI shares?
As of February 28, 2026, the stock is trading at EUR 29.42 with a total of 1,686,634 shares traded.
Over the past week, the price has changed by +6.36%, over one month by +7.29%, over three months by +6.67% and over the past year by +3.14%.
Over the past week, the price has changed by +6.36%, over one month by +7.29%, over three months by +6.67% and over the past year by +3.14%.
Is BVI a buy, sell or hold?
Bureau Veritas has no consensus analysts rating.
What are the forecasts/targets for the BVI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.3 | 13.2% |
| Analysts Target Price | - | - |
BVI Fundamental Data Overview February 26, 2026
Market Cap USD = 14.48b (12.24b EUR * 1.1832 EUR.USD)
P/E Trailing = 19.0207
P/E Forward = 17.3913
P/S = 1.8478
P/B = 8.3986
P/EG = 2.2583
Revenue TTM = 12.49b EUR
EBIT TTM = 1.91b EUR
EBITDA TTM = 2.48b EUR
Long Term Debt = 1.89b EUR (from longTermDebt, last quarter)
Short Term Debt = 341.4m EUR (from shortTermDebt, last quarter)
Debt = 2.58b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.72b EUR (from netDebt column, last quarter)
Enterprise Value = 13.95b EUR (12.24b + Debt 2.58b - CCE 867.5m)
Interest Coverage Ratio = 9.22 (Ebit TTM 1.91b / Interest Expense TTM 207.2m)
EV/FCF = 9.10x (Enterprise Value 13.95b / FCF TTM 1.53b)
FCF Yield = 10.98% (FCF TTM 1.53b / Enterprise Value 13.95b)
FCF Margin = 12.27% (FCF TTM 1.53b / Revenue TTM 12.49b)
Net Margin = 9.31% (Net Income TTM 1.16b / Revenue TTM 12.49b)
Gross Margin = 48.41% ((Revenue TTM 12.49b - Cost of Revenue TTM 6.44b) / Revenue TTM)
Gross Margin QoQ = 23.27% (prev none%)
Tobins Q-Ratio = 2.13 (Enterprise Value 13.95b / Total Assets 6.56b)
Interest Expense / Debt = 1.58% (Interest Expense 40.8m / Debt 2.58b)
Taxrate = 26.06% (119.0m / 456.7m)
NOPAT = 1.41b (EBIT 1.91b * (1 - 26.06%))
Current Ratio = 1.18 (Total Current Assets 2.92b / Total Current Liabilities 2.48b)
Debt / Equity = 1.79 (Debt 2.58b / totalStockholderEquity, last quarter 1.44b)
Debt / EBITDA = 0.69 (Net Debt 1.72b / EBITDA 2.48b)
Debt / FCF = 1.12 (Net Debt 1.72b / FCF TTM 1.53b)
Total Stockholder Equity = 1.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.98% (Net Income 1.16b / Total Assets 6.56b)
RoE = 66.64% (Net Income TTM 1.16b / Total Stockholder Equity 1.74b)
RoCE = 52.52% (EBIT 1.91b / Capital Employed (Equity 1.74b + L.T.Debt 1.89b))
RoIC = 34.72% (NOPAT 1.41b / Invested Capital 4.07b)
WACC = 6.59% (E(12.24b)/V(14.82b) * Re(7.74%) + D(2.58b)/V(14.82b) * Rd(1.58%) * (1-Tc(0.26)))
Discount Rate = 7.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.72%
[DCF] Terminal Value 85.99% ; FCFF base≈1.26b ; Y1≈1.55b ; Y5≈2.64b
[DCF] Fair Price = 136.2 (EV 62.13b - Net Debt 1.72b = Equity 60.41b / Shares 443.7m; r=6.59% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -10.98 | EPS CAGR: -42.03% | SUE: 0.0 | # QB: 0
Revenue Correlation: 34.80 | Revenue CAGR: 9.97% | SUE: 0.03 | # QB: 0
EPS next Year (2026-12-31): EPS=1.56 | Chg7d=+0.002 | Chg30d=+0.004 | Revisions Net=+0 | Growth EPS=+9.6% | Growth Revenue=+5.1%
P/E Trailing = 19.0207
P/E Forward = 17.3913
P/S = 1.8478
P/B = 8.3986
P/EG = 2.2583
Revenue TTM = 12.49b EUR
EBIT TTM = 1.91b EUR
EBITDA TTM = 2.48b EUR
Long Term Debt = 1.89b EUR (from longTermDebt, last quarter)
Short Term Debt = 341.4m EUR (from shortTermDebt, last quarter)
Debt = 2.58b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.72b EUR (from netDebt column, last quarter)
Enterprise Value = 13.95b EUR (12.24b + Debt 2.58b - CCE 867.5m)
Interest Coverage Ratio = 9.22 (Ebit TTM 1.91b / Interest Expense TTM 207.2m)
EV/FCF = 9.10x (Enterprise Value 13.95b / FCF TTM 1.53b)
FCF Yield = 10.98% (FCF TTM 1.53b / Enterprise Value 13.95b)
FCF Margin = 12.27% (FCF TTM 1.53b / Revenue TTM 12.49b)
Net Margin = 9.31% (Net Income TTM 1.16b / Revenue TTM 12.49b)
Gross Margin = 48.41% ((Revenue TTM 12.49b - Cost of Revenue TTM 6.44b) / Revenue TTM)
Gross Margin QoQ = 23.27% (prev none%)
Tobins Q-Ratio = 2.13 (Enterprise Value 13.95b / Total Assets 6.56b)
Interest Expense / Debt = 1.58% (Interest Expense 40.8m / Debt 2.58b)
Taxrate = 26.06% (119.0m / 456.7m)
NOPAT = 1.41b (EBIT 1.91b * (1 - 26.06%))
Current Ratio = 1.18 (Total Current Assets 2.92b / Total Current Liabilities 2.48b)
Debt / Equity = 1.79 (Debt 2.58b / totalStockholderEquity, last quarter 1.44b)
Debt / EBITDA = 0.69 (Net Debt 1.72b / EBITDA 2.48b)
Debt / FCF = 1.12 (Net Debt 1.72b / FCF TTM 1.53b)
Total Stockholder Equity = 1.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.98% (Net Income 1.16b / Total Assets 6.56b)
RoE = 66.64% (Net Income TTM 1.16b / Total Stockholder Equity 1.74b)
RoCE = 52.52% (EBIT 1.91b / Capital Employed (Equity 1.74b + L.T.Debt 1.89b))
RoIC = 34.72% (NOPAT 1.41b / Invested Capital 4.07b)
WACC = 6.59% (E(12.24b)/V(14.82b) * Re(7.74%) + D(2.58b)/V(14.82b) * Rd(1.58%) * (1-Tc(0.26)))
Discount Rate = 7.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.72%
[DCF] Terminal Value 85.99% ; FCFF base≈1.26b ; Y1≈1.55b ; Y5≈2.64b
[DCF] Fair Price = 136.2 (EV 62.13b - Net Debt 1.72b = Equity 60.41b / Shares 443.7m; r=6.59% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -10.98 | EPS CAGR: -42.03% | SUE: 0.0 | # QB: 0
Revenue Correlation: 34.80 | Revenue CAGR: 9.97% | SUE: 0.03 | # QB: 0
EPS next Year (2026-12-31): EPS=1.56 | Chg7d=+0.002 | Chg30d=+0.004 | Revisions Net=+0 | Growth EPS=+9.6% | Growth Revenue=+5.1%